These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16989264)

  • 1. Immunization campaigns in the UK.
    Noakes K; Salisbury D
    Curr Top Microbiol Immunol; 2006; 304():53-70. PubMed ID: 16989264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system.
    Mounier-Jack S; Burchett HE; Griffiths UK; Konate M; Diarra KS
    Glob Health Sci Pract; 2014 Feb; 2(1):117-29. PubMed ID: 25276567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination.
    Trotter CL; McVernon J; Andrews NJ; Burrage M; Ramsay ME
    Lancet; 2003 May; 361(9368):1523-4. PubMed ID: 12737867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The UK Hib vaccine experience.
    Heath PT; McVernon J
    Arch Dis Child; 2002 Jun; 86(6):396-9. PubMed ID: 12023165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass vaccination campaigns for polio eradication: an essential strategy for success.
    Sutter RW; Maher C
    Curr Top Microbiol Immunol; 2006; 304():195-220. PubMed ID: 16989271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The introduction of Haemophilus influenzae type b immunization into the United Kingdom: practical steps to assure success.
    Salisbury DM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S136-9. PubMed ID: 9781747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital rubella syndrome: a matter of concern.
    Martínez-Quintana E; Castillo-Solórzano C; Torner N; Rodríguez-González F
    Rev Panam Salud Publica; 2015 Mar; 37(3):179-86. PubMed ID: 25988255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.
    Cano R; Larrauri A; Mateo S; Alcalá B; Salcedo C; Vázquez JA
    Euro Surveill; 2004 Jul; 9(7):11-5. PubMed ID: 15318008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus toxoid immunization campaign in West Nusa Tenggara, Indonesia.
    UNICEF
    Assignment Child; 1985; (69-72):369-80. PubMed ID: 12340731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mass vaccination campaigns against polio on the utilization of routine immunization services: A regression discontinuity design.
    Helleringer S; Asuming PO; Abdelwahab J
    Vaccine; 2016 Jul; 34(33):3817-22. PubMed ID: 27269060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa.
    Miller MA; Wenger J; Rosenstein N; Perkins B
    Pediatr Infect Dis J; 1999 Dec; 18(12):1051-9. PubMed ID: 10608623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification.
    Garrido-Estepa M; León-Gómez I; Herruzo R; Cano R
    Vaccine; 2014 May; 32(22):2604-9. PubMed ID: 24662700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to evaluating the UK childhood immunisation schedule: estimating the effective coverage vector across the entire vaccine programme.
    Crowe S; Utley M; Walker G; Panovska-Griffiths J; Grove P; Pagel C
    BMC Infect Dis; 2015 Dec; 15():585. PubMed ID: 26714777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.